Buccal and Palatal Bone Thickness and Marginal Bone Changes Implants
Launched by INTERNATIONAL PIEZOSURGERY ACADEMY · Nov 20, 2022
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
despite various recommendations, there is insufficient evidence to set a threshold for minimal buccal bone thickness necessary to ensure peri-implant marginal bone stability and optimal aesthetic outcomes.
Therefore, the aim of the present multi-centre prospective study was to investigate the influence of buccal and palatal bone thickness at the time of implant placement on peri-implant bone remodeling during the submerged healing period, with a strict control of possible confounding factors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \> 18 years;
- • no smokers;
- • no history of periodontal disease;
- • healed bone crest (at least six months after tooth extraction);
- • crestal bone height ≥8 mm;
- • crestal bone with a minimum bucco-palatal width of 6 mm with no concomitant or previous bone augmentation procedures.
- Exclusion Criteria:
- • absolute contraindications to implant surgery
- • immunological or genetic disorders;
- • uncontrolled diabetes (HBA1c \> 7.5%);
- • present or past treatment with anti resorptive drugs;
- • oncologic patients;
- • history of head or neck radiotherapy;
- • alcohol or drugs abuse;
- • final insertion torque \> 50 Ncm.
About International Piezosurgery Academy
The International Piezosurgery Academy (IPA) is a leading organization dedicated to advancing the field of piezosurgery through innovative research, education, and clinical application. With a focus on enhancing surgical techniques and improving patient outcomes, IPA sponsors clinical trials that explore the efficacy and safety of piezoelectric technology in various medical and dental procedures. Committed to fostering collaboration among healthcare professionals, the academy provides comprehensive training programs and resources, positioning itself at the forefront of surgical innovation and excellence in patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cassano Allo Ionio, Cs, Italy
Verona, Vr, Italy
Patients applied
Trial Officials
Claudio Stacchi, Dr
Study Chair
Piezoelectric Surgery Academy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials